Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 14 Dec 2017 |
2 | Reply to Exam Report (MIS-R) | 19 Jan 2018 |
3 | Reply to Exam Report (MIS-R) | 25 Jan 2018 |
4 | Authorization Letter | 06 Jun 2019 |
5 | Journal Copy | 29 Jul 2019 |
6 | TM-O(NOTICE OF OPPOSITION) | 09 Oct 2019 |
7 | Evidence Affidavit Under Rule 46 (TOP) | 18 Mar 2024 |
8 | Annexure -1 under rule 46 | 18 Mar 2024 |
1 | Hearing Notice (Show Cause) | 8220127 | 4094125 | 06 May 2019 |
2 | Tribunal Accepted Notice for : 3702608 | 8379039 | 4130324 | 06 Jun 2019 |
3 | Opposition Notice | 16086519 | 6219864 | 21 Sep 2023 |
4 | Opposition Counter Statement | 16772283 | 6379093 | 11 Dec 2023 |
Dabitra was applied on 14 December 2017.
Trademark application was filed by EMCURE PHARMACEUTICALS.
Trademark application has been filed under following classes.
5
As per IP India, trademark application is on the following stage:
Opposed.
Listed application Id of Dabitra is 3702608.
Trademark attorney of the Dabitra is Aditya & Associates.
Dabitra is a WORD as per IP India data.